MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-28 (cardiovascularbusiness.com)
PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data
Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies.
Read more
2025-04-27 (massdevice.com)
Medtronic reports more positive outcomes with Affera PFA tech
Medtronic (NYSE: MDT) today announced positive clinical outcomes from two studies of its pulsed field ablation (PFA) technologies.
Read more
2025-04-25 (openpr.com)
Cardiac Care Advancements Propel North America Interventional Cardiology Market - Leading Companies are Medtronic, Abbott & Braun SE.
Press release - DataM Intelligence 4market Research LLP - Cardiac Care Advancements Propel North America Interventional Cardiology Market - Leading Companies are Medtronic, Abbott & Braun SE. - published on openPR.com
Read more
2025-04-25 (businessmarketinsights.com)
Until 2028, the Middle East and African colon cancer diagnostic market predicted -Corona 19 influence and regional analysis -video test (colonoscopy, CT colonology, flexible windows, capsule endoscopy, etc.) Inspection) and the end user (hospital, diagnostic laboratory, cancer research institute and other)
The Middle East and African colon cancer diagnostic markets are expected to grow to an annual average growth rate of 6.2%by 2028. The report provides insight into the latest trends.
Read more
2025-04-25 (medcitynews.com)
Orchestra BioMed's Hypertension Device Wins FDA Breakthrough Designation -
Orchestra BioMed's hypertension treatment is the latest medical device to earn the FDA's breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.
Read more
2025-04-24 (prnewswire.com)
Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and...
Read more
2025-04-23 (igj.nl)
Medtronic, FA1474, Hugo Robotic Assisted Surgery (race) System | Warning Healthcare and Youth Inspectorate
The Hugo™ RAS system is designed to enable the safe removal of instruments should they become disabled during a procedure. Medtronic investigation has determined that an excessive torque error is occurring for instruments at an increased occurrence rate. This error prevents further use of the instrument and requires it to be removed.
Read more
2025-04-22 (mexicobusiness.news)
Medtronic, Tempus Target Aortic Stenosis
Medtronic and Tempus partner to use AI for early detection of aortic stenosis by analyzing electronic health records.
Read more
2025-04-22 (medicaleconomics.com)
FDA approves Medtronic's Simplera Sync Sensor for use with MiniMed 780G Insulin System
Device uses an adaptive algorithm to automatically adjust and correct glucose levels every five minutes around the clock.
Read more
2025-04-22 (medpagetoday.com)
Isturisa's New Indication; Wegovy Pill Submitted to FDA; Type 5 Diabetes? | MedPage Today
The FDA expanded the approval of osilodrostat (Isturisa) to include treatment of endogenous hypercortisolemia in adults with Cushing's syndromeopens in a new tab or window for whom surgery is not an option or was not curative, said maker Recordati.
Read more
2025-04-21 (cardiovascularbusiness.com)
Oversizing reduces PVL when implanting Medtronic's newer self-expanding TAVR valves
Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes.
Read more
2025-04-18 (tecnomedicina.it)
The new Simplera Sync sensor for the Medtronic minimed 780g system approved by the FDA -
Medtronic has announced the approval of the US Food and Drug Administration for the Simplera Sync sensor to be used with the Minimed 780g system. With this approval, the Minimed 780g system now offers greater flexibility to users of the company's more advanced insulin administration system, equipped with Meal Detection technology, both with the Guardian sensor 4 [...]
Read more